Aspen Aerogels, Inc. Logo

Aspen Aerogels, Inc.

ASPN

(0.8)
Stock Price

28,76 USD

-8.76% ROA

-10.05% ROE

-18.29x PER

Market Cap.

1.067.300.238,00 USD

33.2% DER

0% Yield

-18.42% NPM

Aspen Aerogels, Inc. Stock Analysis

Aspen Aerogels, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aspen Aerogels, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (6%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.8x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 ROE

Negative ROE (-12.4%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-8.76%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-75) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Aspen Aerogels, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aspen Aerogels, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Aspen Aerogels, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aspen Aerogels, Inc. Revenue
Year Revenue Growth
2001 121.622.000
2009 28.616.000 -325.01%
2010 43.209.000 33.77%
2011 45.950.000 5.97%
2012 63.453.000 27.58%
2013 86.094.000 26.3%
2014 102.399.000 15.92%
2015 122.518.000 16.42%
2016 117.738.000 -4.06%
2017 111.631.000 -5.47%
2018 104.361.000 -6.97%
2019 139.375.000 25.12%
2020 100.273.000 -39%
2021 121.622.000 17.55%
2022 180.364.000 32.57%
2023 243.020.000 25.78%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aspen Aerogels, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 11.441.000
2009 2.524.000 -353.29%
2010 2.985.000 15.44%
2011 4.085.000 26.93%
2012 5.142.000 20.56%
2013 5.159.000 0.33%
2014 5.980.000 13.73%
2015 5.253.000 -13.84%
2016 5.306.000 1%
2017 6.180.000 14.14%
2018 6.319.000 2.2%
2019 8.407.000 24.84%
2020 8.729.000 3.69%
2021 11.441.000 23.7%
2022 16.930.000 32.42%
2023 16.872.000 -0.34%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aspen Aerogels, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 22.514.000
2009 5.430.000 -314.62%
2010 5.675.000 4.32%
2011 8.914.000 36.34%
2012 11.299.000 21.11%
2013 13.418.000 15.79%
2014 16.853.000 20.38%
2015 15.068.000 -11.85%
2016 17.415.000 13.48%
2017 19.023.000 8.45%
2018 19.116.000 0.49%
2019 16.479.000 -16%
2020 15.681.000 -5.09%
2021 22.514.000 30.35%
2022 38.499.000 41.52%
2023 63.360.000 39.24%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aspen Aerogels, Inc. EBITDA
Year EBITDA Growth
2001 -40.599.000
2009 -9.952.000 -307.95%
2010 -2.862.000 -247.73%
2011 -17.736.000 83.86%
2012 -23.289.000 23.84%
2013 -12.994.000 -79.23%
2014 -16.043.000 19.01%
2015 -6.235.000 -157.31%
2016 -11.876.000 47.5%
2017 -19.136.000 37.94%
2018 -26.560.000 27.95%
2019 -14.159.000 -87.58%
2020 -21.569.000 34.35%
2021 -40.599.000 46.87%
2022 -77.628.000 47.7%
2023 -58.536.000 -32.62%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aspen Aerogels, Inc. Gross Profit
Year Gross Profit Growth
2001 9.937.000
2009 -3.634.000 373.45%
2010 5.691.000 163.86%
2011 -2.626.000 316.72%
2012 -7.968.000 67.04%
2013 10.731.000 174.25%
2014 17.080.000 37.17%
2015 24.648.000 30.7%
2016 23.311.000 -5.74%
2017 18.671.000 -24.85%
2018 12.669.000 -47.38%
2019 26.284.000 51.8%
2020 14.594.000 -80.1%
2021 9.937.000 -46.87%
2022 4.976.000 -99.7%
2023 55.240.000 90.99%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aspen Aerogels, Inc. Net Profit
Year Net Profit Growth
2001 -37.094.000
2009 -18.639.000 -99.01%
2010 -9.910.000 -88.08%
2011 -32.832.000 69.82%
2012 -56.142.000 41.52%
2013 -47.611.000 -17.92%
2014 -66.324.000 28.21%
2015 -6.417.000 -933.57%
2016 -12.023.000 46.63%
2017 -19.321.000 37.77%
2018 -34.440.000 43.9%
2019 -4.758.000 -623.83%
2020 -11.851.000 59.85%
2021 -27.883.000 57.5%
2022 -86.231.000 67.66%
2023 -52.292.000 -64.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aspen Aerogels, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2009 -1 100%
2010 -1 0%
2011 -2 100%
2012 -4 33.33%
2013 -2 -50%
2014 -5 60%
2015 0 0%
2016 -1 0%
2017 -1 0%
2018 -1 100%
2019 0 0%
2020 0 0%
2021 -1 0%
2022 -2 100%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aspen Aerogels, Inc. Free Cashflow
Year Free Cashflow Growth
2009 -14.616.000
2010 -26.467.000 44.78%
2011 -60.457.000 56.22%
2012 -36.115.000 -67.4%
2013 -17.017.000 -112.23%
2014 -6.593.000 -158.11%
2015 -16.597.000 60.28%
2016 -13.794.000 -20.32%
2017 -10.724.000 -28.63%
2018 -12.247.000 12.44%
2019 -3.166.000 -286.83%
2020 -13.340.000 76.27%
2021 -32.406.000 58.83%
2022 -272.373.000 88.1%
2023 -5.734.000 -4650.14%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aspen Aerogels, Inc. Operating Cashflow
Year Operating Cashflow Growth
2009 -12.972.000
2010 -15.126.000 14.24%
2011 -24.153.000 37.37%
2012 -25.879.000 6.67%
2013 -13.688.000 -89.06%
2014 6.648.000 305.9%
2015 5.359.000 -24.05%
2016 -578.000 1027.16%
2017 -4.606.000 87.45%
2018 -8.654.000 46.78%
2019 -1.054.000 -721.06%
2020 -9.924.000 89.38%
2021 -18.628.000 46.73%
2022 -94.399.000 80.27%
2023 -5.734.000 -1546.3%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aspen Aerogels, Inc. Capital Expenditure
Year Capital Expenditure Growth
2009 1.644.000
2010 11.341.000 85.5%
2011 36.304.000 68.76%
2012 10.236.000 -254.67%
2013 3.329.000 -207.48%
2014 13.241.000 74.86%
2015 21.956.000 39.69%
2016 13.216.000 -66.13%
2017 6.118.000 -116.02%
2018 3.593.000 -70.28%
2019 2.112.000 -70.12%
2020 3.416.000 38.17%
2021 13.778.000 75.21%
2022 177.974.000 92.26%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aspen Aerogels, Inc. Equity
Year Equity Growth
2009 6.153.000
2010 -58.103.000 110.59%
2012 -34.545.000 -68.2%
2013 -61.966.000 44.25%
2014 123.716.000 150.09%
2015 122.474.000 -1.01%
2016 115.564.000 -5.98%
2017 100.943.000 -14.48%
2018 70.254.000 -43.68%
2019 58.990.000 -19.09%
2020 67.852.000 13.06%
2021 128.408.000 47.16%
2022 447.435.000 71.3%
2023 409.813.000 -9.18%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aspen Aerogels, Inc. Assets
Year Assets Growth
2009 64.735.000
2010 88.795.000 27.1%
2012 95.301.000 6.83%
2013 90.442.000 -5.37%
2014 145.043.000 37.64%
2015 140.074.000 -3.55%
2016 134.669.000 -4.01%
2017 123.815.000 -8.77%
2018 99.023.000 -25.04%
2019 103.502.000 4.33%
2020 97.424.000 -6.24%
2021 182.954.000 46.75%
2022 646.570.000 71.7%
2023 605.146.000 -6.85%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aspen Aerogels, Inc. Liabilities
Year Liabilities Growth
2009 58.582.000
2010 146.898.000 60.12%
2012 129.846.000 -13.13%
2013 152.408.000 14.8%
2014 21.327.000 -614.62%
2015 17.600.000 -21.18%
2016 19.105.000 7.88%
2017 22.872.000 16.47%
2018 28.769.000 20.5%
2019 44.512.000 35.37%
2020 29.572.000 -50.52%
2021 54.546.000 45.79%
2022 203.232.000 73.16%
2023 195.333.000 -4.04%

Aspen Aerogels, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.09
Net Income per Share
-0.76
Price to Earning Ratio
-18.29x
Price To Sales Ratio
4.98x
POCF Ratio
-15.6
PFCF Ratio
-4.52
Price to Book Ratio
2.37
EV to Sales
5.18
EV Over EBITDA
-20.17
EV to Operating CashFlow
-17.84
EV to FreeCashFlow
-4.69
Earnings Yield
-0.05
FreeCashFlow Yield
-0.22
Market Cap
1,07 Bil.
Enterprise Value
1,11 Bil.
Graham Number
10.09
Graham NetNet
-0.62

Income Statement Metrics

Net Income per Share
-0.76
Income Quality
1.13
ROE
-0.12
Return On Assets
-0.06
Return On Capital Employed
-0.08
Net Income per EBT
0.96
EBT Per Ebit
0.93
Ebit per Revenue
-0.21
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.25
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.24
Operating Profit Margin
-0.21
Pretax Profit Margin
-0.19
Net Profit Margin
-0.18

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.9
Free CashFlow per Share
-3.41
Capex to Operating CashFlow
2.8
Capex to Revenue
-0.81
Capex to Depreciation
-13.1
Return on Invested Capital
-0.1
Return on Tangible Assets
-0.09
Days Sales Outstanding
92.76
Days Payables Outstanding
78.55
Days of Inventory on Hand
72.84
Receivables Turnover
3.93
Payables Turnover
4.65
Inventory Turnover
5.01
Capex per Share
-2.51

Balance Sheet

Cash per Share
1,37
Book Value per Share
5,91
Tangible Book Value per Share
5.91
Shareholders Equity per Share
5.91
Interest Debt per Share
1.96
Debt to Equity
0.33
Debt to Assets
0.22
Net Debt to EBITDA
-0.75
Current Ratio
3.27
Tangible Asset Value
0,41 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.33
Working Capital
0,14 Bil.
Intangibles to Total Assets
0
Average Receivables
0,05 Bil.
Average Payables
0,04 Bil.
Average Inventory
33855000
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aspen Aerogels, Inc. Dividends
Year Dividends Growth

Aspen Aerogels, Inc. Profile

About Aspen Aerogels, Inc.

Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.

CEO
Mr. Donald R. Young
Employee
548
Address
Building B
Northborough, 01532

Aspen Aerogels, Inc. Executives & BODs

Aspen Aerogels, Inc. Executives & BODs
# Name Age
1 Mr. Ricardo C. Rodriguez
Chief Financial Officer & Treasurer
70
2 Mr. Neal Baranosky
Senior Director of Corporate of Strategy & Finance
70
3 Ms. Stephanie Pittman
Chief Human Resources Officer
70
4 Mr. Gregg R. Landes
Senior Vice President of Operations & Strategic Development
70
5 Ms. Virginia H. Johnson
Chief Legal Officer, General Counsel, Chief Compliance Officer & Corporate Secretary
70
6 Mr. Santhosh P. Daniel
Chief Accounting Officer
70
7 Mr. Donald R. Young
President, Chief Executive Officer & Director
70
8 Mr. Corby C. Whitaker
Senior Vice President of Sales & Marketing
70
9 Mr. Keith L. Schilling
Senior Vice President of Technology
70
10 Dr. George L. Gould J.D., Llm., Ph.D.
Chief Technology Officer
70

Aspen Aerogels, Inc. Competitors